瑞典登记数据:被诊断为性别焦虑者的死亡率几乎是配对对照组的两倍

2001–2023年瑞典性别焦虑个体全因及特定原因死亡率的全国估计:一项基于登记的队列研究

Authors
Kristen D. Clark, Richard A. White, Sarah S. Jackson, Alkistis Skalkidou, Thomas Frisell, Fotios C. Papadopoulos
Journal
EClinicalMedicine
Year
2026

Summary

Swedish researchers found everyone diagnosed with gender dysphoria in national health records between 2001 and 2023, about 9,000 people who were about 25 on average when diagnosed. They compared deaths with men and women of the same age and county. Over about seven years, 211 people with gender dysphoria died, almost twice the death rate of the comparison groups after allowing for age. Extra deaths came from accidents, violence and suicide (suicide was not counted on its own), from unclear causes, from mental and brain conditions such as drug or alcohol problems, and from cancer in people born female. The authors call for public health action but say the records cannot explain why. Nothing beyond age and county was taken into account, and many causes had very few deaths. So the study shows a gap in deaths but not what causes it.

Key findings

  • 该研究涵盖了2001至2023年间瑞典9,038名被诊断为性别焦虑的人(4,181名出生时为男性,4,857名出生时为女性),与179,816名同年龄、同郡的人作比较。
  • 共有211人死亡;考虑年龄后,死亡率为每年每1万人183例对96例,约为两倍。
  • 在出生时为男性的人中,死亡率是女性的2.3倍、男性的1.6倍,事故、暴力和自杀(3.2倍和2.5倍)、原因不明(约5倍)以及精神或脑部疾病(3.6倍和2.6倍)导致的死亡更多。
  • 在出生时为女性的人中,死亡率是女性的2.1倍、男性的1.7倍,事故、暴力和自杀(2.2倍和1.5倍)以及癌症(2.4倍和1.8倍)导致的死亡更多。
  • 自杀、谋杀和事故合计导致211例死亡中的76例(36%),但自杀没有单独报告。
  • 平均而言,出生时为男性的人(与男性相比)每例死亡提前6年,出生时为女性的人(与女性相比)提前9年。
  • 作者说,这些发现是追踪死亡情况的起点,而不是关于原因或治疗效果的证据。

Abstract

BACKGROUND: Transgender and gender-diverse (TGD) people experience elevated mortality risk, yet population-based estimates of cause-specific mortality remain limited. Prior studies have focused on narrow subgroups or outdated cohorts, leaving gaps in understanding current mortality disparities. Therefore, the purpose of this study is to quantify all-cause and cause-specific mortality among all TGD adults with a diagnosis of gender dysphoria in Sweden. METHODS: This cohort study provides national cause-specific mortality estimates among TGD adults in Sweden using registry data (2001-2023). TGD people were identified using ICD-10 codes for "gender dysphoria" and matched to approximately 10 cisgender controls of each sex by age and county. Age-standardized mortality rates, absolute mortality risk differences, mortality rate ratios (MRR), and years of potential life lost (YPLL) were calculated overall and stratified by sex assigned at birth. FINDINGS: A total of 9038 TGD people were identified, among them, 211 deaths were observed. All-cause mortality risk was almost twice that of the cisgender comparison group (MRR = 1.9, 95% confidence interval [CI] 1.7, 2.2). Stratified analyses showed distinct mortality patterns for transfeminine (assigned male sex at birth) and transmasculine (assigned female sex at birth) people, with higher risk from ill-defined diseases among transfeminine people (cisgender women as reference: MRR = 4.9, 95% CI 2.3, 10.3; cisgender men: MRR = 5.5, 95% CI 2.6, 11.4) and transmasculine people from neoplasms (cisgender women: MRR = 2.4, 95% CI 1.4, 4.1; cisgender men: MRR = 1.8, 95% CI 1.1, 3.1). These disparities resulted in a mean of 6.3 YPLL for transfeminine people compared to cisgender men and 9.0 YPLL for transmasculine people compared to cisgender women. INTERPRETATION: These findings highlight persistent health inequities and underscore the need for targeted public health interventions and an evaluation of data collection processes to improve health monitoring and support TGD populations in Sweden. FUNDING: The present study was funded by a Starting Grant (2023-01397) and a project grant (2021-01968) from the Swedish Research Council for Health, Working Life and Welfare (FORTE).

Conclusion

These findings highlight persistent health inequities and underscore the need for targeted public health interventions and an evaluation of data collection processes to improve health monitoring and support TGD populations in Sweden. The authors note that registry data cannot distinguish whether excess deaths result from biological factors, behavioural risks, systemic barriers or administrative biases. They state that future research linking clinical treatment records to mortality is required, and that the findings serve primarily as a baseline for monitoring mortality trends rather than evidence of specific causal pathways.